(19)
(11) EP 4 463 145 A1

(12)

(43) Date of publication:
20.11.2024 Bulletin 2024/47

(21) Application number: 22834342.2

(22) Date of filing: 01.07.2022
(51) International Patent Classification (IPC): 
A61K 31/191(2006.01)
A23L 33/00(2016.01)
 A61P 3/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/191; A61P 3/04; A23L 33/30; A23L 33/10; A23L 33/115; A23L 33/15; A23L 33/16; A61K 31/522; A61K 45/06
 
C-Sets:
  1. A61K 31/522, A61K 2300/00;
  2. A61K 31/191, A61K 2300/00;
(86) International application number:
PCT/US2022/036030
(87) International publication number:
WO 2023/278881 (05.01.2023 Gazette 2023/01)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 02.07.2021 US 202117367206

(71) Applicant: Axcess Global Sciences, LLC
Salt Lake City, UT 84106 (US)

(72) Inventors:
  • LOWERY, Ryan
    Tampa, Florida 33607 (US)
  • WILSON, Jacob
    Tampa, Florida 33609 (US)
  • LACORE, Terry
    Melissa, Texas 75454 (US)

(74) Representative: Schwarz & Partner Patentanwälte GmbH 
Patentanwälte Wipplingerstraße 30
1010 Wien
1010 Wien (AT)

   


(54) ADMINISTRATION OF R-BETA-HYDROXYBUTYRATE AND RELATED COMPOUNDS IN HUMANS